Haemorrhagic shock secondary to aorto-enteric fistula after treatment with bevacizumab for metastatic colorectal cancer: review of the literature

Julia López de la Cruz
DOI: https://doi.org/10.17235/reed.2024.10773/2024
2024-09-19
Abstract:We present the case of a 57-year-old woman with metastatic colorectal cancer being treated with Bevacizumab and FOLFOX, who came to the emergency department with haematemesis. Gastroscopy showed a duodenal ulcer without active bleeding. Subsequently, he suffered haemodynamic instability and an Angio-CT scan revealed an aortoenteric fistula, requiring urgent surgery. Bevacizumab can cause rare complications such as this, and early detection is crucial for effective treatment.
What problem does this paper attempt to address?